09.20.24 -- The High Life And Times Of A Qualified Person (QP) In Europe

This webinar highlights the use of PBPK modeling software like GastroPlus® to simulate drug properties and interactions, reducing unnecessary testing. We'll cover solid form screening, formulation maps for amorphous solid dispersions, and criteria for salt screening, emphasizing how these tools can guide early drug form selection and enhance bioavailability. Register now to learn more.

Content uniformity is one of the most important release criteria for solid dosage forms. In continuous manufacturing, what process analytical technologies (PAT) are available to measure and assure content uniformity as part of a real time release (RTR) strategy?

Chief Editor Louis Garguilo instigates a bit of philosophic thought in panelists Sriram Naganathan, REVOLUTION Biologics, and Kirsteen Keith, Immunocore, when it comes to strategic alliances with CDMOs.

Learn how innovative, emerging technologies are revolutionizing the field of bioanalytics and drug development.

We share important factors to consider when weighing your contract service provider options. These “Three Cs” can indicate whether a provider has the capabilities desired by sponsors.

As the pharmaceutical fine chemicals industry strives towards sustainable innovation, CDMOs are considering how best to implement process adaptations, renewable raw materials, and green chemistry to reduce carbon footprints.

When preparing for IND submission, developers must consider multiple components. Explore tips for optimizing your early development program and the benefits of housing all activities under one roof.

An optimized service offering can simplify and accelerate the development pathway, even for APIs with challenging properties, such as low aqueous solubility and poor bioavailability.

Join the next Outsourced Pharma Live as our panel explores the critical considerations and best practices for selecting and managing CDMOs in the development of novel therapies, including advanced therapy medicinal products like cell and gene therapies. Industry experts will share insights on evaluating CDMO capabilities, ensuring quality and compliance, and fostering effective partnerships to accelerate innovation while mitigating risks.

Grace's FCMS offers comprehensive research and development services and is equipped to handle all your product development needs and bring your projects from concept to production.

Learn how DTP clinical supply enables participants to receive treatments in the comfort of their own homes while reducing the need to travel to a clinical site.

Ensuring commercial success at every juncture, we employ a consultative and phase-appropriate methodology that's tailored to your specific needs.

We are manufacturing, packaging, and supply chain experts, harnessing experience and expertise to deliver you a seamless solution with the ultimate aim of improving the lives of patients.